TSNAX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.822200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.546400E-01
Normal-vs-Stage2
3.230000E-01
Normal-vs-Stage3
4.305600E-02
Normal-vs-Stage4
8.753400E-01
Stage1-vs-Stage2
8.546000E-02
Stage1-vs-Stage3
4.191600E-02
Stage1-vs-Stage4
7.216400E-01
Stage2-vs-Stage3
1.116040E-01
Stage2-vs-Stage4
4.090800E-01
Stage3-vs-Stage4
1.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.448800E-01
Normal-vs-AfricanAmerican
9.387400E-01
Normal-vs-Asian
2.780200E-01
Caucasian-vs-AfricanAmerican
1.523600E-01
Caucasian-vs-Asian
8.288200E-01
AfricanAmerican-vs-Asian
1.218030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.535200E-01
Normal-vs-Female
4.427600E-01
Male-vs-Female
5.692800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.145200E-01
Normal-vs-Age(41-60Yrs)
5.725200E-01
Normal-vs-Age(61-80Yrs)
3.372000E-01
Normal-vs-Age(81-100Yrs)
2.526400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.115800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.444200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.694000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.309800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.645200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.545800E-01
Normal-vs-Daily Drinker
7.468000E-02
Normal-vs-Weekly Drinker
1.647990E-01
Normal-vs-Occasional Drinker
8.419200E-01
Normal-vs-Social Drinker
5.311000E-01
Non Drinker-vs-Daily Drinker
6.449800E-02
Non Drinker-vs-Weekly Drinker
4.140600E-01
Non Drinker-vs-Occasional Drinker
1.221020E-01
Non Drinker-vs-Social Drinker
5.979800E-01
Daily Drinker-vs-Weekly Drinker
4.465600E-01
Daily Drinker-vs-Occasional Drinker
7.224900E-03
Daily Drinker-vs-Social Drinker
6.943800E-02
Weekly Drinker-vs-Occasional Drinker
7.289700E-02
Weekly Drinker-vs-Social Drinker
3.079200E-01
Occasional Drinker-vs-Social Drinker
4.544400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.703500E-02
Normal-vs-Grade 2
3.875600E-03
Normal-vs-Grade 3
2.921800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.988600E-01
Grade 1-vs-Grade 3
8.416800E-01
Grade 1-vs-Grade 4
5.703500E-02
Grade 2-vs-Grade 3
6.466000E-01
Grade 2-vs-Grade 4
3.875600E-03
Grade 3-vs-Grade 4
2.921800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.273180E-01
Normal-vs-NonDiabetic
3.258600E-01
Diabetic-vs-NonDiabetic
7.742100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.301600E-02
Normal-vs-NoPancreatitis
3.256000E-01
Pancreatitis-vs-NoPancreatitis
1.054820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.398800E-01
Normal-vs-N1
2.938000E-01
N0-vs-N1
9.155700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.964000E-01
Normal-vs-TP53-NonMutant
8.144600E-01
TP53-Mutant-vs-TP53-NonMutant
6.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
